Eric A. Klein

External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.

H. Levin, E. Klein, R. Macklis, 1997, The cancer journal from Scientific American.

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk

B. Trock, E. Klein, S. Freedland, 2016, Prostate Cancer and Prostatic Disease.

Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative group

H. Klocker, M. Kattan, E. Steyerberg, 2011, World Journal of Urology.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

P. Carroll, R. Stoyanova, A. Tewari, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice.

M. Kattan, E. Steyerberg, E. Klein, 2008, The Journal of urology.

Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels.

J. Ciezki, A. Stephenson, M. Gong, 2009, European Urology.

Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy

M. Kattan, P. Scardino, M. Zelefsky, 2004 .

Localized prostate cancer

P. Kupelian, Eric A. Klein, 2000, Current treatment options in oncology.

The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy.

C. Magi-Galluzzi, E. Klein, A. Stephenson, 2010, European urology.